Lifestyle Intervention for Obesity
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a new method to help African American adults in economically disadvantaged areas manage obesity and related health risks. It involves a 12-week lifestyle program using "house chats" to encourage weight loss in a community setting. Participants will either start the program immediately or have a delayed start. Adults living in Petersburg, VA, who are not dealing with certain medical conditions like type 1 diabetes or cancer, might be a good fit.
As an unphased trial, this study offers a unique opportunity to participate in innovative research aimed at improving community health.
Do I have to stop taking my current medications?
The trial protocol does not specify if you need to stop taking your current medications. However, if you are currently using weight loss medication, you cannot participate in the trial.
What prior data suggests that this lifestyle intervention is safe?
Research has shown that a 12-week lifestyle program is generally safe for adults with obesity. In previous studies, participants handled these programs well, with no reports of serious side effects. Many participants saw health improvements, such as better weight control and reduced risks for heart disease. This suggests the program is safe and could assist those seeking to manage their weight and health.12345
Why are researchers excited about this trial?
Unlike typical treatments for obesity that often rely on medication or surgery, this lifestyle intervention focuses on behavior changes. Researchers are excited about this approach because it empowers individuals to adopt healthier habits over a 12-week period, potentially leading to sustainable weight loss without medical intervention. This method emphasizes personalized guidance and support, making it a promising alternative for those seeking long-term solutions to manage obesity.
What evidence suggests that this 12-week lifestyle intervention is effective for obesity?
Research has shown that a 12-week lifestyle program can help people lose a significant amount of weight. For instance, one study found that participants lost at least 5% of their body weight, a meaningful reduction for those with obesity. Another study demonstrated that these programs improved health by promoting regular exercise and healthy eating. These programs often include group meetings or online platforms to support participants, making them accessible and effective. In this trial, participants will either receive the 12-week lifestyle intervention immediately or join a delayed intervention control group, with both groups receiving the same program. Overall, evidence suggests that a 12-week lifestyle program can effectively manage weight and improve health.16789
Who Is on the Research Team?
Moghboeba Mosavel
Principal Investigator
Virginia Commonwealth University
Are You a Good Fit for This Trial?
This trial is for African American adults who are at least 18 years old and live in Petersburg, VA. It's designed to help those living in economically disadvantaged areas reduce obesity and improve heart health through a community-based program.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a 12-week lifestyle intervention delivered via weekly group meetings in the HCL's homes
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments at 12 and 24 weeks post-treatment
Long-term follow-up
Mixed methods approach to assess factors that might promote and/or interfere with sustainability over long-term follow-up
What Are the Treatments Tested in This Trial?
Interventions
- 12-week lifestyle intervention
12-week lifestyle intervention is already approved in United States for the following indications:
- Weight loss
- Obesity prevention
- Cardiometabolic disease prevention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Virginia Commonwealth University
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator